Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression

Vincenzo Serretta; Rosalinda Allegro; Antonio Russo; Antonina Cangemi; Andrea Cocci; Fabrizio Di Maida; Riccardo Tellini; Simone Sforza; Andrea Mari; Lorenzo Masieri; Andrea Minervini; Marco Carini; Cristina Scalici Gesolfo

Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression

Vincenzo Serretta, Rosalinda Allegro, Antonio Russo, Antonina Cangemi, Andrea Cocci, Fabrizio Di Maida, Riccardo Tellini, Simone Sforza, Andrea Mari, Lorenzo Masieri, Andrea Minervini, Marco Carini, Cristina Scalici Gesolfo

Risultato della ricerca: Article › peer review

7 Citazioni (Scopus)

Abstract

The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.

Lingua originale	English
Numero di pagine	0
Rivista	Clinical Genitourinary Cancer
Stato di pubblicazione	Published - 2019

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2730???
???subjectarea.asjc.2700.2748???

Altri file e collegamenti

OA Link

Fingerprint

Entra nei temi di ricerca di 'Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression'. Insieme formano una fingerprint unica.

Cita questo

Serretta, V., Allegro, R., Russo, A., Cangemi, A., Cocci, A., Di Maida, F., Tellini, R., Sforza, S., Mari, A., Masieri, L., Minervini, A., Carini, M., & Scalici Gesolfo, C. (2019). Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression. Clinical Genitourinary Cancer.

Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression. / Serretta, Vincenzo ; Allegro, Rosalinda ; Russo, Antonio ; Cangemi, Antonina; Cocci, Andrea; Di Maida, Fabrizio; Tellini, Riccardo; Sforza, Simone; Mari, Andrea; Masieri, Lorenzo; Minervini, Andrea; Carini, Marco; Scalici Gesolfo, Cristina.

In: Clinical Genitourinary Cancer, 2019.

Risultato della ricerca: Article › peer review

Serretta, V , Allegro, R , Russo, A , Cangemi, A, Cocci, A, Di Maida, F, Tellini, R, Sforza, S, Mari, A, Masieri, L, Minervini, A, Carini, M & Scalici Gesolfo, C 2019, 'Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression', Clinical Genitourinary Cancer.

Serretta, Vincenzo ; Allegro, Rosalinda ; Russo, Antonio ; Cangemi, Antonina ; Cocci, Andrea ; Di Maida, Fabrizio ; Tellini, Riccardo ; Sforza, Simone ; Mari, Andrea ; Masieri, Lorenzo ; Minervini, Andrea ; Carini, Marco ; Scalici Gesolfo, Cristina. / Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression. In: Clinical Genitourinary Cancer. 2019.

@article{9d9b81c3e9224dfa97adec6871bac5a7,

title = "Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression",

abstract = "The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.",

author = "Vincenzo Serretta and Rosalinda Allegro and Antonio Russo and Antonina Cangemi and Andrea Cocci and {Di Maida}, Fabrizio and Riccardo Tellini and Simone Sforza and Andrea Mari and Lorenzo Masieri and Andrea Minervini and Marco Carini and {Scalici Gesolfo}, Cristina",

year = "2019",

language = "English",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

}

TY - JOUR

T1 - Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression

AU - Serretta, Vincenzo

AU - Allegro, Rosalinda

AU - Russo, Antonio

AU - Cangemi, Antonina

AU - Cocci, Andrea

AU - Di Maida, Fabrizio

AU - Tellini, Riccardo

AU - Sforza, Simone

AU - Mari, Andrea

AU - Masieri, Lorenzo

AU - Minervini, Andrea

AU - Carini, Marco

AU - Scalici Gesolfo, Cristina

PY - 2019

Y1 - 2019

N2 - The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.

AB - The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.

UR - http://hdl.handle.net/10447/359492

M3 - Article

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

ER -